Audience
Health care professionals including physicians, physician assistants, nurse practitioners and nurses.
Goal
To provide up-to-date information
Objectives
- Review the most recent data on the effects of the HPV vaccine
- Define cross-protection and identify possible cross-protective benefits of HPV vaccines
- Discuss optimal ways to talk with patients and parents about the benefits of HPV immunization
Presenters
Darron Brown, MD - Indiana University School of Medicine
E.J. Mayeaux, MD - Louisiana State University - Health Sciences
Kenneth Alexander, MD - University of Chicago
Credits Available
Physicians- 0.5 credit hours of AMA/PRA Category 1 credit
Nurses- 0.5 nursing contact hours (0.5 in the area of pharmacology)
All other health care professionals will receive a certificate of participation
Advances
in the Management of Non-Ovarian Female Pelvic Malignancies
National Comprehensive Cancer Network
Web Site
http://www.medscape.com/viewprogram/5766_learning#Target
Audience
This educational activity is designed to meet the educational
needs of physicians, nurses and other clinical professionals
who manage patients with cancer.
Objectives
1. Summarize the recent advances in cancer prevention vaccine
research
2. Describe the role of HPV in the etiology of cervical
cancer
3. Discuss the rationale for immunizing women against HPV
as a strategy to prevent cervical cancer.
Credit hours
Physicians – up to 0.5 AMA PRA Category 1 Credit(s)
for physicians;
Nurses – 0.5 ANCC continuing education contact hours
for nurses
All other healthcare professionals completing continuing
education credit for this activity will be issued a certificate
of participation.
Human Papillomavirus:
What You Need to Know
Webcast Postgraduate Institute for Medicine
Web Site
http://www.adolescenthealth.org/cme/program_hpv/
Audience
This activity has been designed to meet the educational
needs of pediatricians, family practitioners, and adolescent
medicine specialists involved in the care of adolescent
patients with HPV/cervical cancer.
Objectives
After completing this activity, the participants should
be better able to:
1. Describe the prevalence, risks and outcomes of cervical
cancer and how it pertains to adolescent females.
2. Explain HPV viral transmission and its link to cervical
cancer
3. Specify oncogenic HPV types and their roles in causing
cervical cancer
4. Discuss the diversity of HPV types and the need to develop
broad spectrum immunological vaccines
5. Discuss strategies to effectively communicate to parents
the benefits of HPV vaccination.
Credit Hours
Postgraduate Institute of Medicine designates this educational
activity for a maximum of 1.25 AMA PRA Category 1 Credit(s).
Physicians should only claim credit commensurate with the
extent of their participation in the activity.
Reducing the Global Burden of HPV - Related Disease: Cervical Cancer and Beyond
Sci Med
Accredited through 11/27/2008
Web Site
http://www.medscape.com/viewprogram/8073
Audience
This activity has been designed for infectious disease specialists, researchers, and other health care professionals that wish to learn more about preventing HPV-related cancers and other diseases.
Goal
This symposium will review the pathogenesis of HPV infection, the epidemiology of lesser-known HPV associated diseases and the role of HPV vaccination in preventing HPV-related cancers and other diseases.
Presenters
Joel Palefski, MD
Maura Gillison, MD
Craig Derkay, MD
This is a four-part series covering the topics of:
- HPV Overview
- HPV-Related Disease in Men; Anal and Penile Cancer
- HPV-Related Head and Neck Cancers
Credit
Physicians - up to 1.5 AMA/PRA Category 1 credit
All other health care professionals completing continuing education credit for this activity will be issued a certificate of participation.
Public Health Impact of HPV Vaccination: Aligning Policy with Science
SciMed
Accredited through 8/12/2008
Web Site
http://www.medscape.com/viewprogram/7219?src=0_nl_cme_9
Audience
This activity has been designed to meet the educational needs of infectious disease specialists and other health care professionals who wish to learn more about preventing cervical cancer and other HPV-related diseases.
Goal:
This presentation will review the burden of HPV-associated diease in the United States, the safety and efficacy of HPV vaccines, and key implementation and policy issues that will affect uptake of HPV vaccine and therefore the impact of vaccination on the burden of HPV-associated diseases.
Presenters
Mark Kane, MD
Kenneth Alexander, MD
Kevin Ault, MD
This is a three-part series covering the topics of:
- Disease Burden and Health Consequences of HPV
- HPV Vaccine Update- Efficacy and Potential Population Impact
- HPV Immunization in the U.S.: Implementation and Policy Issues
Credit
Physicians- Up to 1.5 AMA/PRA Category 1 credit
All other health care professionals completing continuing education for this activity will be issued a certificate of participation.
Exploring the Link Between HPV & Cervical Cancer
Web Site
www.healthed.org/Training/HPV.htm
Information
Sponsored by the California Family Health Council, Inc.
Online Training Module
Training format: Audio presentation
Duration: 60 minutes
Credit Hours
Physicians & Physician Assistants- up to 1.0 contact hours of Category 1 credits toward the California Medical Association's Certification in Continuing Medical Education and the American Medical Association Physician's Recognition Award. The AAPA and ACNM accept Category 1 CME approval.
Nurse Practitioners- provider approved by the California Board of Registered Nursing, Provider #CEP 12241 for up to 1.2 contact hours.
